Prolonged Methylprednisolone Treatment Suppresses Systemic Inflammation in Patients with Unresolving Acute Respiratory Distress Syndrome: Evidence for Inadequate Endogenous Glucocorticoid Secretion and Inflammation-induced Immune Cell Resistance to Glucocorticoids
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Nuclear factor- κ B (NF- κ B) and glucocorticoid receptor- α (GR- α ) have diametrically opposed functions in regulating inflammation. We investigated whether unresolving acute respiratory distress syndrome (ARDS) is associated with systemic inflammation- induced glucocorticoid resistance and whether prolonged methylprednisolone administration accelerates the suppression of systemic inflammatory indices and normalizes the sensitivity of the immune system to glucocorticoids. Patients enrolled into a randomized trial evaluating prolonged methylprednisolone administration in unresolving ARDS had serial plasma samples collected before and after randomization. In the plasma, we measured the concentrations of tumor necrosis factor- α (TNF- α ), interleukins (IL) IL-1 β and IL-6, adrenocorticotropic hormone (ACTH), and cortisol. The ability of patient plasma to influence the NF- κ B and GR-signal transduction systems of normal peripheral blood leukocytes (PBL) was examined. Patients treated with methylprednisolone had progressive and sustained reductions of TNF- α, IL-1 β, IL-6, ACTH, and cortisol concentrations over time. Normal PBL exposed to plasma samples collected during methylprednisolone exhibited significant progressive increases in all aspects of GR-mediated activity and significant reductions in NF- κ B DNA-binding and transcription of TNF- α and IL-1 β. These findings provide support for the presence of endogenous glucocorticoid inadequacy in the control of inflammation and systemic inflammation-induced peripheral glucocorticoid resistance in ARDS. Prolonged methylprednisolone administration accelerated the resolution of both systemic inflammation and peripheral acquired glucocorticoid resistance in ARDS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“since GR-α upregulation was shown to augment the effects of available glucocorticoids [81].”
In the citing paper
“In contrast, plasma samples from patients with sustained elevation in inflammatory cytokine levels elicited only modest longitudinal increases in GC-GRα-mediated activity and a progressive increase in NF-kB nuclear binding over time that was most striking in non-survivors (suggesting a dysregulated, NF-kB-driven response).”
In the citing paper
“Treatment with glucocorticoids led to a change in the longitudinal direction of systemic inflammation from dysregulated (NF-kB-driven response, maladaptive lung repair) to regulated (GRα-driven response, adaptive lung repair), with significant reduction in indices of alveolar-capillary membrane permeability and markers of inflammation, hemostasis, and tissue repair.”
In the citing paper
“Ex vivo experiments suggest that, in ARDS, insufficient GC-GRα-mediated activity is a central mechanism for the upregulation of NF-kB activity [7,81].”
In the citing paper
“Similarly, in an ex vivo ARDS study, prolonged methylprednisolone treatment-contrary to placebo-was associated with upregulation in GRα number, GRα binding to NF-kB, GRα nuclear translocation leading to reduction in NF-kB DNA-binding and transcription of inflammatory cytokines [81].”
Citations
Cites
Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M., Legall, J. R., Morris, A., & Spragg, R. (1994) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.149.3.7509706 · Cited by 6,746
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
An Expanded Definition of the Adult Respiratory Distress Syndrome
Murray, J. F., Matthay, M. A., Luce, J. M., & Flick, M. R. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.3.720 · Cited by 2,646
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Meduri, G. U., Headley, A. S., Golden, E., Carson, S. J., Umberger, R. A., Kelso, T., & Tolley, E. A. (1998) · JAMA · doi:10.1001/jama.280.2.159 · Cited by 1,008
Self-citationAnnane, D. (2000) · JAMA · doi:10.1001/jama.283.8.1038 · Cited by 1,000
Molecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889
Self-citationMcKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805 · cited 1×
“Two cellular signaling pathways are central to the host inflammatory response, the stimulatory nuclear factor- B (NF- B) and the inhibitory glucocorticoid receptor- (GR- )-mediated signal transduction cascades (3).”
BackgroundPersistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS
Meduri, G. U., Headley, S., Kohler, G., Stentz, F., Tolley, E., Umberger, R., & Leeper, K. (1995) · Chest · doi:10.1378/chest.107.4.1062 · Cited by 789
Self-citationInterleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human Monocytes
Wang, P., Wu, P., Siegel, M. I., Egan, R. W., & Billah, M. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9558 · Cited by 711
NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.
Baeuerle, P. A., & Baichwal, V. R. (1997) · PubMed · Cited by 615
Slutsky, A. S. (1993) · Chest · doi:10.1378/chest.104.6.1833 · Cited by 563
Baeuerle, P. A., & Baichwal, V. R. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60742-7 · Cited by 511
Role of NFkappaB in the mortality of sepsis.
Böhrer, H., Qiu, F., Zimmermann, T., Zhang, Y., Jllmer, T., Männel, D., Böttiger, B. W., Stern, D. M., Waldherr, R., Saeger, H. D., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119648 · Cited by 454
Kam, J. C., Szefler, S. J., Surs, W., Sher, E. R., & Leung, D. Y. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3460 · Cited by 449
Sher, E. R., Leung, D. Y., Surs, W., Kam, J. C., Zieg, G., Kamada, A. K., & Szefler, S. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116963 · Cited by 393
Molecular mechanisms of anti‐inflammatory action of glucocorticoids
Cato, A. C. B., & Wade, E. (1996) · BioEssays · doi:10.1002/bies.950180507 · Cited by 309
Sheppard, K.-A., Phelps, K. M., Williams, A. J., Thanos, D., Glass, C. K., Rosenfeld, M. G., Gerritsen, M. E., & Collins, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29291 · Cited by 305
Krafft, P., Fridrich, P., Pernerstorfer, T., Fitzgerald, R. D., Koc, D., Schneider, B., Hammerle, A. F., & Steltzer, H. (1996) · Intensive Care Medicine · doi:10.1007/bf01708091 · Cited by 244
Melby, J. C., & Spink, W. W. (1958) · Journal of Clinical Investigation · doi:10.1172/jci103772 · Cited by 237
Syndromes of Glucocorticoid Resistance
Chrousos, G. P., Detera-Wadleigh, S. D., & Karl, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-11-199312010-00009 · Cited by 235
Self-citationA Dual Mechanism Mediates Repression of NF-κB Activity by Glucocorticoids
Wissink, S., van Heerde, E. C., van der Burg, B., & van der Saag, P. T. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.3.0081 · Cited by 225
McKay, L. I. (1999) · Endocrine Reviews · doi:10.1210/er.20.4.435 · Cited by 223
UMBERTO MEDURI, G., TOLLEY, E. A., CHINN, A., STENTZ, F., & POSTLETHWAITE, A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9801107 · Cited by 186
Self-citationAlmawi, W. Y., Lipman, M. L., Stevens, A. C., Zanker, B., Hadro, E. T., & Strom, T. B. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3523 · Cited by 170
Glucocorticoid Resistance in Asthma
Barnes, P. J., Greening, A. P., & Crompton, G. K. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/152.6_pt_2.s125 · Cited by 157
A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity
Spahn, J. D., Szefler, S. J., Surs, W., Doherty, D. E., Nimmagadda, S. R., & Leung, D. Y. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2654 · Cited by 155
Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma.
Adcock, I. M., Lane, S. J., Brown, C. R., Peters, M. J., Lee, T. H., & Barnes, P. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.7.3500 · Cited by 153
Reincke, M. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.1.151 · Cited by 147
Plasma and BAL Cytokine Response to Corticosteroid Rescue Treatment in Late ARDS
Meduri, G. U., Headley, S., Tolley, E. A., Shelby, M., Stentz, F. B., & Postlethwaite, A. E. (1995) · CHEST Journal · doi:10.1378/chest.108.5.1315 · Cited by 140
Self-citationCortisol receptor resistance: the variability of its clinical presentation and response to treatment
Lamberts, S. W. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.2.313 · Cited by 139
Cortisol resistance in acquired immunodeficiency syndrome
Norbiato, G. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.3.608 · Cited by 131
Molijn, G. J. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.6.1799 · Cited by 125
Increased nuclear factor κB activation in critically ill patients who die
Paterson, R. L., Galley, H. F., Dhillon, J. K., & Webster, N. R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00022 · Cited by 110
Molecular Mechanisms of Immunosuppression and Anti-inflammatory Activities by Glucocorticoids
Didonato, J. A., Saatcioglu, F., & Karin, M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.2_pt_2.s11 · Cited by 79
Lane, S. J., & Lee, T. H. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.5_pt_1.1020 · Cited by 68
Meduri, G. U. (1999) · Sepsis · doi:10.1023/a:1009870524359 · Cited by 59
Self-citationHofmann, T. G., Hehner, S. P., Bacher, S., Dröge, W., & Schmitz, M. L. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01609-3 · Cited by 59
Contribution of cortisol deficiency to septic shock
Briegel, J., Forst, H., Hellinger, H., & Haller, M. (1991) · The Lancet · doi:10.1016/0140-6736(91)90575-a · Cited by 54
Duration of Glucocorticoid Treatment and Outcome in Sepsis
Meduri, G. U., & Chrousos, G. P. (1998) · CHEST Journal · doi:10.1378/chest.114.2.355-a · Cited by 54
Self-citationLiu, L.-Y., Sun, B., Tian, Y., Lu, B.-Z., & Wang, J. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.4_pt_1.878 · Cited by 51
Effect of glucocorticoid receptor (GR) blockade on endotoxemia in rats.
Fan, J., Gong, X., Wu, J., Zhang, Y., & Xu, R.-B. (1994) · PubMed · Cited by 32
Research works printed but not linked: 1
- Bernard, 1995, Quantification of organ failure for clinical trials [abstract]., Am J Respir Crit Care Med, 151, A323
Cited by
Corticosteroid insufficiency in acutely ill patients
Cooper, M. S., & Stewart, P. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020529 · Cited by 1,033
Hydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study
Confalonieri, M., Urbino, R., Potena, A., Piattella, M., Parigi, P., Puccio, G., Della Porta, R., Giorgio, C., Blasi, F., Umberger, R., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-808oc · Cited by 857
Self-citationMethylprednisolone Infusion in Early Severe ARDS
Meduri, G. U., Golden, E., Freire, A. X., Taylor, E., Zaman, M., Carson, S. J., Gibson, M., & Umberger, R. (2007) · Chest · doi:10.1378/chest.06-2100 · Cited by 787
Self-citationNovel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
Cytokine-mediated inflammation in acute lung injury
Goodman, R. B., Pugin, J., Lee, J. S., & Matthay, M. A. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00059-5 · Cited by 688
Metadata
- Authors
- Meduri, G. U., Tolley, E. A., Chrousos, G. P., & Stentz, F.
- Affiliations
- National Institutes of Health (US)
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-04-01
- Volume
- 165
- Issue
- 7
- Pages
- 983-991
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2104968736
- Cited by
- 265
- References
- 43
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 7 · 2023: 9 · 2022: 11 · 2021: 10 · 2020: 12 · 2019: 6 · 2018: 4 · 2017: 6 · 2016: 11 · 2015: 4 · 2014: 8 · 2013: 6 · 2012: 8
- FWCI
- 18.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- acute respiratory distress syndrome, methylprednisolone, glucocorticoid resistance, systemic inflammation, NF-κB, glucocorticoid receptor, cortisol, ACTH, TNF-α, interleukin-6, IL-1β, peripheral blood leukocytes, glucocorticoid sensitivity
- MeSH terms
- Adrenocorticotropic Hormone, Double-Blind Method, Female, Glucocorticoids, Humans, Hydrocortisone, Male, Methylprednisolone, Middle Aged, Receptors, Glucocorticoid, Respiratory Distress Syndrome, Signal Transduction, Transcriptional Activation, Cytokines, NF-kappa B, Systemic Inflammatory Response Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.